Pirifibrate

TargetMol
Product Code: TAR-T34080
Supplier: TargetMol
CodeSizePrice
TAR-T34080-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34080-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34080-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Pirifibrate can be used for the treatment of hyperlipoproteinemia.
CAS:
21550-30-1
Formula:
C17H19Cl2NO4
Molecular Weight:
372.24
Purity:
0.98
SMILES:
Cl.CC(C)(Oc1ccc(Cl)cc1)C(=O)OCc1cccc(CO)n1

References

Bonora V, Calalabuig RJ, Caviola E, Soler J, Pueyo JM, Mical? T, Cano RP. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations. Clin Ther. 1981;4(3):192-200. PubMed PMID: 7030489. Lopez Rodriguez J, Martorell J. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV. Clin Ther. 1980;3(4):234-41. PubMed PMID: 7273061. de la Fuente R, Santos M. [Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)]. Arch Farmacol Toxicol. 1980 Dec;6(3):255-64. Spanish. PubMed PMID: 7305456. Domingo AJ, Guti?rrez JA, Men?ndez JA, Mic? L, Mu?oz M, de Oya M. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study. Clin Ther. 1980;3(3):219-26. PubMed PMID: 7459931.